![](/img/cover-not-exists.png)
PMH13 CHARACTERISTICS AND COST OUTCOMES OF INSURED PATIENTS TREATED WITH EXTENDED-RELEASE NALTREXONE (XR-NTX) OR ORAL ALCOHOL DEPENDENCE MEDICATIONS
TL Mark, DR Gastfriend, HR Kranzler, M Chalk, L MontejanoVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72509-2
File:
PDF, 77 KB
english, 2010